Roche India Atezolizumab marketing approval to be revoked for two indications: CDSCO panel Susmita Roy10 March 2022 1:20 PM GMTNew Delhi: In a major setback to Roche Products (India), the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO)...
Newer Vaccine may prevent Triple Negative Breast Cancer for the first time Dr Nisanth Puliyath12 Feb 2022 3:30 AM GMTThe Cleveland Clinic has begun clinical testing of a novel vaccine designed ultimately to prevent triple-negative breast cancer (TNBC) by priming...
Merck Keytruda in combination with chemotherapy gets European nod as treatment for breast cancer Ruchika Sharma24 Oct 2021 4:00 AM GMTKenilworth: Merck, known as MSD outside the United States and Canada, has recently announced that the European Commission (EC) has approved KEYTRUDA,...
Statins use associated with better survival in patients with triple-negative breast cancer, study finds Hina Zahid10 Aug 2021 5:15 AM GMTTexas: Initiation of statin therapy in the 12 months after a breast cancer diagnosis is associated with better survival rates in triple-negative...
Gilead Sciences application for breast cancer therapy gets EMA validation Ruchika Sharma28 March 2021 5:30 AM GMTFoster City: Gilead Sciences has recently announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application...
